Plus therapeutics announces reverse stock split

Austin, texas, april 28, 2023 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that the company's board of directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-15. the reverse stock split will become effective at 12:01 a.m. eastern time on may 1, 2023, and the company's common stock will open for trading on the nasdaq capital market on a post-split basis on may 1, 2023 under the company's existing trading symbol, “pstv.” at such time, the company's common stock will also commence trading with a new cusip number, 72941h509.
PSTV Ratings Summary
PSTV Quant Ranking